[09]亨廷顿舞蹈症3期临床试验的最新进展:哌啶对亨廷顿舞蹈症功能的影响

{"title":"[09]亨廷顿舞蹈症3期临床试验的最新进展:哌啶对亨廷顿舞蹈症功能的影响","authors":"R. Reilmann, A. Feigin, A. Rosser, S. Kostyk, M. Geva, Noga Gershoni-Emek, D. Boot, Yael Cohen, Y. P. Goldberg, M. R. Hayden","doi":"10.1136/jnnp-2022-ehdn.259","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":251913,"journal":{"name":"J: Clinical therapeutics","volume":"362 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"J09 An update on the proof-HD phase 3 trial: pridopidine’s outcome on function in huntington\",\"authors\":\"R. Reilmann, A. Feigin, A. Rosser, S. Kostyk, M. Geva, Noga Gershoni-Emek, D. Boot, Yael Cohen, Y. P. Goldberg, M. R. Hayden\",\"doi\":\"10.1136/jnnp-2022-ehdn.259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":251913,\"journal\":{\"name\":\"J: Clinical therapeutics\",\"volume\":\"362 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"J: Clinical therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jnnp-2022-ehdn.259\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"J: Clinical therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jnnp-2022-ehdn.259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}